Work

Multi-ancestry genetic analysis reveals 29 novel rheumatoid arthritis loci, effector genes and drug repurposing opportunities

Year: 2026
Type: article
Study design: Observational Study
Abstract: Rheumatoid arthritis (RA) is a complex autoimmune disease with a substantial heritable component. We perform multi-ancestry genome-wide association meta-analyses of 351,498 individuals (comprising 39,600 RA cases and 311,898 controls) by integrating published and new datasets. This analysis identifies 29 novel RA susceptibility loci and systematically classifies association signals as population-specific, population-dominant, or population-shared between East Asian and European populations. Bayesian fine-mapping and functional annotation prioritize putative causal variants, highlighting 67 variants with posterior inclusion probability>0.1 in novel loci, including an SLC27A6 missense variant (rs137898880) and a STIM1 3′ UTR variant (rs3750996). Our gene-prioritization framework combining genetic and biological evidence identifies 203 high-confidence effector genes, 16 of which reside in novel loci (e.g., IFI16 , AIM2 , RGS1 , ITPKB , CD80 , RHOH , NFKB1 , SIK3 , and CCND2 ). Colocalization analysis leveraging tissue-specific eQTL datasets provides mechanistic insights by implicating shared causal variants underlying RA association signals. Notably, the transcription factor gene RUNX3 at a novel locus shows evidence of cis -regulation in immune cells, and RUNX3-binding sites are enriched for variants explaining excess RA heritability, suggesting a potential role for RUNX3 as a trans -regulatory mediator of RA risk at distal RA loci. Finally, exploratory gene-drug interaction networks weighted by RA association strength highlight population-informed therapeutic opportunities and drug-repurposing targets driven largely by novel loci.
Language: English
Subfield: Rheumatology
Field: Medicine
Open Access status: gold
Estimated APC paid: $6,990
OpenAlex ID: W7232058951
FWCI:
Cites:
Cited by:
Related to: 10